市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Care Facilities (US) | 混合的 | 混合的 |
| Medical Care Facilities (全球的) | 看涨 | 混合的 | |
| 股票 | Biote Corp. | 混合的 | 混合的 |
相关股票
| 股票 | 市值 | DY | P/E（TTM） | P/B |
|---|---|---|---|---|
| BTMD | - | - | - | - |
| DCGO | - | - | - | 0.210 |
| PIII | - | - | - | - |
| AIRS | - | - | - | 0.540 |
| JYNT | - | - | - | 7.68 |
| NIVF | - | - | - | - |
AIStockmoo 评分
| 价值 35% | 2.5 |
| AI Insight 参考 | NA |
| 相对估值 参考 | NA |
| 财务健康 参考 | 2.5 |
| 时机 35% | 0.7 |
| AI Technical 参考 | NA |
| 技术振荡指标 参考 | -0.5 |
| 技术平均移动指标 参考 | 2.5 |
| 聪明钱 30% | 0.0 |
| 分析师共识 参考 | 0.0 |
| 内部交易活动 参考 | NA |
| 新闻情绪 参考 | NA |
| 市场环境 | ×0.91 |
| 宏观环境 参考 | -3.3 |
| 行业对比大市 (6个月) | +7.7% |
| 支柱一致性 | ×1.25 |
| 不计入评分 | |
| 价格波动 参考 | 2.2 |
| 最终评分 | 1.27 |
|
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements. |
|
| 部门 | Healthcare |
| 行业 | Medical Care Facilities |
| 投资方式 | Small Value |
| 内部持股比例 | 13.02% |
| 机构持股比例 | 65.98% |
该时间范围内无数据。
该时间范围内无数据。
投资组合